How many different allergy medications can you take at once is a question many UK patients ask, particularly during peak pollen season when a single treatment feels insufficient. The answer depends on which medicines are being combined, how they work, and your individual health profile. Some combinations — such as an intranasal corticosteroid alongside a non-sedating antihistamine — are clinically recognised and supported by NICE guidance. Others, such as taking two oral antihistamines simultaneously, offer no added benefit and increase the risk of side effects. This guide explains the key classes of allergy medicine available in the UK, which combinations are safe, and when to seek professional advice.

Types of Allergy Medications Available in the UK

UK allergy medicines include antihistamines, intranasal corticosteroids, decongestants, mast cell stabilisers, and leukotriene receptor antagonists, each working through a different mechanism to relieve allergic symptoms.

Allergy medications in the UK fall into several distinct categories, each working through a different mechanism to relieve symptoms. Understanding these categories is the first step in using them safely and effectively.

Antihistamines are the most commonly used allergy medicines. They work by blocking histamine H1 receptors, reducing symptoms such as sneezing, itching, and a runny nose. They are available in two main forms:

• First-generation antihistamines (e.g., chlorphenamine/Piriton): effective but can cause significant drowsiness

• Second-generation antihistamines (e.g., cetirizine, loratadine, fexofenadine): less sedating and generally preferred for daytime use

Antihistamines are also available as intranasal sprays (e.g., azelastine) and eye drops for more targeted relief. A combination intranasal spray containing azelastine and fluticasone is available on prescription and is recommended by NICE for moderate-to-severe allergic rhinitis when a single agent is insufficient.

Intranasal corticosteroids (e.g., beclometasone, fluticasone) are nasal sprays that reduce inflammation in the nasal passages. NICE recommends these as a first-line treatment for moderate-to-severe allergic rhinitis due to their sustained anti-inflammatory effect. Licensing and recommended age ranges vary between products; always check the patient information leaflet or ask a pharmacist.

Still have questions? Message our pharmacists for free →

Decongestants (e.g., pseudoephedrine, xylometazoline) relieve nasal congestion by constricting blood vessels. They are available as oral tablets or nasal sprays, though nasal spray forms should not be used for more than seven consecutive days due to the risk of rebound congestion (rhinitis medicamentosa).

Mast cell stabilisers such as sodium cromoglicate (available as eye drops or nasal sprays) prevent the release of histamine from mast cells and are particularly useful for allergic conjunctivitis. Antihistamine or combined antihistamine/mast cell stabiliser eye drops (e.g., olopatadine, azelastine eye drops) are also widely used for ocular allergy symptoms.

Leukotriene receptor antagonists (e.g., montelukast) are prescription-only medicines occasionally used for allergic rhinitis, particularly when asthma coexists. Each class targets a different part of the allergic response, which is why combinations are sometimes considered clinically appropriate.

Sources: NICE CKS: Allergic rhinitis; NHS: Hay fever medicines; BNF.

Is It Safe to Take More Than One Allergy Medication at Once?

Combining medicines from different classes — such as an intranasal corticosteroid and a non-sedating antihistamine — is often safe and clinically recognised, but combining two medicines from the same class (e.g., two oral antihistamines) is not recommended.

Many people wonder whether it is safe to use multiple allergy medications simultaneously, particularly during high-pollen seasons or when symptoms are difficult to control with a single treatment. The answer depends on which specific medicines are being combined and the individual's overall health profile.

In general, combining medicines from different classes is often considered acceptable and is sometimes recommended by healthcare professionals. For example, using an intranasal corticosteroid spray alongside a non-sedating oral antihistamine is a well-recognised approach for managing moderate-to-severe allergic rhinitis, as supported by NICE Clinical Knowledge Summaries. These two medicines work through complementary mechanisms and do not typically interact harmfully. Similarly, an oral antihistamine may be used alongside intranasal or ocular antihistamine preparations when advised by a clinician.

However, combining medicines from the same class carries greater risk. Taking two different oral antihistamines together — for instance, cetirizine and loratadine — is not recommended, as this does not provide additional benefit and increases the likelihood of side effects such as excessive sedation, dry mouth, urinary retention, and blurred vision. Similarly, using two decongestant products concurrently (for example, an oral decongestant tablet alongside a decongestant nasal spray) offers no therapeutic advantage and increases the risk of cardiovascular side effects.

Experiencing these side effects? Our pharmacists can help you navigate them →

It is also important to consider hidden antihistamine content in over-the-counter products. Many cold and flu remedies, sleep aids, and travel sickness tablets contain antihistamines (such as diphenhydramine or promethazine). Taking these alongside a prescribed or purchased antihistamine can inadvertently result in a double dose. Always read the full ingredient list on any over-the-counter product before combining it with other allergy treatments, and when in doubt, consult a pharmacist before starting any new medicine.

Sources: NICE CKS: Allergic rhinitis; NHS: Antihistamines.

Common Interactions Between Allergy Treatments to Be Aware Of

First-generation antihistamines enhance CNS depressants including alcohol and benzodiazepines; oral decongestants must not be taken with MAOIs and require caution in cardiovascular disease, hypertension, and glaucoma.

Drug interactions are an important consideration when using multiple allergy medications. While many combinations are safe, some carry clinically significant risks that patients should be aware of.

Antihistamines and central nervous system (CNS) depressants represent one of the most important interaction categories. First-generation antihistamines such as chlorphenamine have significant sedative properties and can enhance the effects of:

• Alcohol

• Benzodiazepines (e.g., diazepam)

• Opioid analgesics

• Sleeping tablets

• Certain antidepressants

This combination can lead to excessive drowsiness, impaired coordination, and reduced reaction time — posing a particular risk when driving or operating machinery. Even second-generation antihistamines can impair driving in some individuals; do not drive if you feel drowsy.

Decongestants and cardiovascular medicines also warrant caution. Oral decongestants such as pseudoephedrine can raise blood pressure and heart rate. They are contraindicated in people with severe or uncontrolled hypertension and severe coronary artery disease. They should be used with caution — and only after seeking pharmacist or GP advice — in people with cardiovascular disease, hyperthyroidism, diabetes, glaucoma, or an enlarged prostate (benign prostatic hyperplasia). They may also interfere with antihypertensive medicines such as beta-blockers and ACE inhibitors.

Important: Pseudoephedrine and other sympathomimetic decongestants must not be taken with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI, due to the risk of a potentially life-threatening hypertensive crisis. If you are taking or have recently taken an MAOI, tell your pharmacist or GP before using any decongestant.

The MHRA and EMA have also issued a safety communication (2024) noting rare but serious risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with pseudoephedrine. Stop taking pseudoephedrine and seek urgent medical attention if you develop a sudden severe headache, confusion, visual disturbances, or other neurological symptoms.

Montelukast (a leukotriene receptor antagonist) has relatively few drug interactions, but the MHRA has issued guidance noting a potential association with neuropsychiatric side effects, including mood changes, sleep disturbances, and in rare cases, suicidal ideation. If you or your child experience any of these symptoms whilst taking montelukast, stop the medicine and seek medical advice promptly.

Intranasal and inhaled corticosteroids, when used together (for example, in patients with both allergic rhinitis and asthma), contribute to total corticosteroid exposure. Whilst systemic absorption from nasal sprays is generally low at standard doses, systemic effects can occur with high doses or prolonged use. Growth should be monitored in children using intranasal corticosteroids long-term. Additionally, strong CYP3A4 inhibitors — such as ritonavir or cobicistat (used in HIV treatment) — can significantly increase plasma levels of fluticasone even when used as a nasal spray, potentially causing systemic corticosteroid effects including adrenal suppression. If you are taking any HIV medicines or other strong CYP3A4 inhibitors, discuss this with your GP or pharmacist before using fluticasone-containing products.

If you suspect you have experienced a side effect from any allergy medicine, please report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Sources: MHRA Drug Safety Update: Montelukast (2019, updated 2022); MHRA/EMA: Pseudoephedrine and rare risks of PRES/RCVS (2024); MHRA/EMC SmPC: Pseudoephedrine; MHRA/EMC SmPC: Fluticasone nasal spray; NHS: Decongestants; BNF.

NHS and NICE Guidance on Combining Allergy Medicines

NICE recommends a stepwise approach: a non-sedating antihistamine or intranasal corticosteroid for mild symptoms, progressing to combination therapy for moderate-to-severe allergic rhinitis; two oral antihistamines together are not routinely recommended.

NICE and NHS guidance provides a clear framework for the stepwise management of allergic conditions, particularly allergic rhinitis and urticaria, which helps inform decisions about combining treatments.

1. For allergic rhinitis, NICE Clinical Knowledge Summaries recommend a stepwise approach:
2. Mild intermittent symptoms: a non-sedating oral antihistamine or intranasal antihistamine as monotherapy
3. Moderate-to-severe or persistent symptoms: an intranasal corticosteroid, with or without an oral antihistamine. The combination azelastine/fluticasone nasal spray is an option at this stage. For troublesome rhinorrhoea, ipratropium nasal spray may be considered. Short courses of oral corticosteroids are occasionally used by clinicians for severe, acute flares, but this is not routine self-management.
4. Inadequate response: consider adding a short-term nasal decongestant, referral to a specialist, or allergen immunotherapy

For chronic urticaria, NICE guidance recommends non-sedating antihistamines as first-line treatment. If symptoms are not controlled at standard doses, the dose may be increased — up to four times the standard dose in adults and young people aged 12 and over. This higher dosing is off-label and should only be undertaken under the supervision of a GP or specialist. If symptoms remain inadequately controlled, referral for specialist review is appropriate. Specialist options for refractory chronic spontaneous urticaria include omalizumab (approved by NICE in Technology Appraisal TA339) and, in selected cases, ciclosporin.

The NHS advises patients to use the lowest effective dose of any allergy medicine for the shortest necessary duration, particularly for decongestants and sedating antihistamines. Intranasal corticosteroids are considered safe for long-term use when used as directed, making them a preferred option for ongoing symptom management.

Importantly, NICE does not recommend routinely combining two oral antihistamines, as evidence does not support improved efficacy over a single optimised dose. Patients who feel their symptoms are not adequately controlled on a single agent should seek professional advice rather than self-medicating with additional over-the-counter products.

Sources: NICE CKS: Allergic rhinitis; NICE CKS: Urticaria; NICE TA339: Omalizumab for chronic spontaneous urticaria; NHS: Hay fever.

When to Seek Advice From a GP or Pharmacist

Consult a pharmacist before combining allergy medicines if you take regular prescribed medicines, are pregnant or breastfeeding, or are buying for a child; call 999 immediately if signs of anaphylaxis develop.

Whilst many allergy medications are available without prescription, there are important situations where professional guidance is essential before combining or continuing treatments.

Consult a pharmacist if you are:

• Unsure whether two products you are considering contain the same active ingredient

• Taking regular prescribed medicines and wish to add an over-the-counter allergy treatment

• Pregnant or breastfeeding — loratadine or cetirizine are generally considered the preferred antihistamine options during pregnancy based on available safety data, but you should seek advice before use. Decongestants should be avoided in pregnancy unless specifically advised by a healthcare professional. For breastfeeding, seek pharmacist or GP advice, as recommendations vary by medicine.

• Buying allergy medicines for a child, as age restrictions and dosing differ significantly between products

Contact your GP if:

• Your allergy symptoms are not adequately controlled despite using recommended over-the-counter treatments

• You experience side effects such as palpitations, significant drowsiness, urinary difficulties, or mood changes

• You have a pre-existing condition such as hypertension, glaucoma, an enlarged prostate, or liver or kidney disease, as these may affect which medicines are safe for you

• You are taking multiple prescribed medicines and are unsure about interactions

Call NHS 111 for urgent advice about allergy symptoms that are worsening but are not immediately life-threatening, such as spreading hives without any breathing difficulty or other systemic symptoms.

Call 999 immediately if you or someone else shows signs of anaphylaxis, which include:

• Difficulty breathing, wheezing, or noisy breathing

• Swelling of the tongue, lips, or throat

• Hoarseness or difficulty swallowing

• Dizziness, collapse, or loss of consciousness

• Rapid or weak pulse

Pharmacists in the UK are highly trained medicines experts and are an excellent first point of contact for questions about allergy medication combinations. Many GP surgeries also offer allergy-focused consultations, and referral to a specialist allergy clinic may be appropriate for complex or severe cases.

Sources: NHS: Anaphylaxis; NHS: Hay fever and pregnancy; SPS: Antihistamines in pregnancy and breastfeeding.

Managing Allergies Safely: Practical Tips for UK Patients

Keep a full medicines record, read labels for active ingredients to avoid duplicate antihistamines, use correct intranasal spray technique, and apply non-pharmacological measures such as monitoring pollen forecasts and saline nasal rinses.

Effective allergy management goes beyond simply choosing the right medication — it involves a considered, consistent approach that minimises risk whilst maximising symptom control.

Keep a record of all medicines you take, including over-the-counter products, vitamins, and herbal remedies. This is particularly important when visiting a GP or pharmacist, as it allows them to identify potential interactions quickly. The NHS App can help you keep track of your prescriptions.

Read labels carefully before purchasing any over-the-counter product. Look for active ingredients rather than brand names, as many products contain the same antihistamine under different labels. If you are already taking cetirizine, for example, avoid purchasing any product that also lists cetirizine or another antihistamine as an ingredient.

Use your intranasal spray correctly. Incorrect technique is a common reason for poor symptom control. Tilt your head slightly forward, insert the nozzle gently into one nostril aiming away from the nasal septum, and breathe in gently through the nose as you spray. Ask your pharmacist to demonstrate the correct technique if you are unsure.

Non-pharmacological measures can significantly reduce the need for multiple medications:

• Monitor pollen forecasts (available via the Met Office) and limit outdoor activity on high-pollen days

• Shower and change clothes after spending time outdoors during pollen season

• Consider saline nasal rinses or sprays to help clear allergens from the nasal passages

• Use allergen-proof bedding covers if house dust mite allergy is a trigger

• Keep windows closed during peak pollen times (typically early morning and early evening)

Allergen immunotherapy (desensitisation) is available on the NHS for selected patients with severe allergic rhinitis or insect venom allergy. It requires specialist referral, confirmed IgE-mediated sensitisation, and is considered after an inadequate response to pharmacotherapy and allergen avoidance measures. It may reduce long-term reliance on multiple medications. Discuss this option with your GP if your symptoms are significantly affecting your quality of life.

Finally, never exceed recommended doses in an attempt to improve symptom control. If standard doses are insufficient, this is a signal to seek professional review rather than to self-escalate treatment. If you think you have experienced a side effect from any allergy medicine, report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app. Safe, effective allergy management is always best achieved in partnership with a qualified healthcare professional.

Sources: NHS: Hay fever self-care; BSACI rhinitis guidance; Met Office: UK pollen forecast; MHRA Yellow Card scheme.

Frequently Asked Questions